BerGenBio is Drug Discovery in Norway that focus on drug candidate bemcentinib business. Founded in 2007. They cover business area such as BerGenBio ASA, therapeutic, novel drug target, aggressive cancer, its drug candidate bemcentinib, clinical development.
2007
( 17 years old in 2024 )
Drug Candidate Bemcentinib
-
Jonas Lies vei 91
5009 Bergen
Norway
Private
BerGenBio ASAtherapeuticnovel drug targetaggressive cancerits drug candidate bemcentinibclinical development
* We use standard office opening hours in near BerGenBio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
BerGenBio is Drug Discovery business from Norway that founded in 2007 (17 years old in 2024), BerGenBio business is focusing on Drug Candidate Bemcentinib.
BerGenBio headquarter office and corporate office address is located in Jonas Lies vei 91 5009 Bergen Norway.
BerGenBio was founded in Norway.
In 2024, BerGenBio is currently focus on drug candidate bemcentinib sector.
Above is snippet of Google Trends for "drug candidate bemcentinib" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with BerGenBio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
